Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Sage Therapeutic (SAGE)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sage Therapeutic's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create a new watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
73.88 -0.28    -0.38%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
72.80
-1.08
-1.46%
17:33:59 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US78667J1088 
CUSIP:  78667J108
  • Volume: 319,283
  • Bid/Ask: 69.00 / 79.87
  • Day's Range: 72.83 - 76.97
Sage Therapeutic 73.88 -0.28 -0.38%

SAGE Earnings

 
The latest earnings per stock, revenues and financial reports for Sage Therapeutic (SAGE).
Latest Release

May 04, 2021

EPS / Forecast

-1.64 / -1.87

Revenue / Forecast

1.58M / 2.03M

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Aug 10, 2021 06/2021 -- /  -1.69 -- /  2.05M
May 04, 2021 03/2021 -1.64 /  -1.87 1.58M /  2.03M
Feb 24, 2021 12/2020 18.19 /  -2.08 1.11B /  1.95M
Nov 05, 2020 09/2020 -2.03 /  -2.3 1.64M /  1.84M
Aug 10, 2020 06/2020 -2.63 /  -2.56 1.09M /  877.19K
May 07, 2020 03/2020 -2.44 /  -3.02 2.29M /  2.78M
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

SAGE Comments

Write your thoughts about Sage Therapeutic
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Episcopolian OptionTrader
Episcopolian1 Dec 22, 2020 10:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Stock up before the phase2 dat for Essential tremor SAGE-324 is out
Reply
0 0
Report
Inca Lama
Inca Lama Mar 25, 2020 8:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
🤑🤑🤑after all this lockdown and toilet paper scarcity depression treatment will be an even more tremendously flourishing business! major depression! not to mention the babies who will born because couples lockdown together!!! postpartum depression!!!great timing for the company to handle the aftermath of coronavirus!!!🚀🚀🚀
Reply
1 0
Report
fernando pimentel
fernando pimentel Dec 30, 2019 8:56PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i will sell at 150great money maker
Reply
2 1
Report
fernando pimentel
fernando pimentel Dec 30, 2019 8:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
perfect time to enter
Reply
2 0
Report
Sushil Lulla
Sushil Lulla Dec 10, 2019 8:53AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bought some yesterday . will buy more if it goes below 60 .
Reply
0 0
Report
Sushil Lulla
Sushil Lulla Dec 10, 2019 8:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bought some yesterday . will buy more if it goes below 60 .
Reply
0 0
Report
Boldizsár Nagy
Boldizsár Nagy Dec 06, 2019 7:08AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Discounted.
Reply
2 0
Report
Nael Km
Nael Km Dec 06, 2019 6:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hi all recommended to buy or not!!
Reply
0 0
Report
Lex Talionis
Lex Talionis Dec 05, 2019 3:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Daily chart looking like it walked off a cliff, Wil E. Coyote style.
Reply
0 0
Report
David Trépanier
David Trépanier Dec 05, 2019 10:08AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ooopsie holders
Reply
1 0
Report
gianmis Hamham
gianmis Hamham Dec 05, 2019 10:08AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
OK made me lough
Reply
1 0
Report
Erski Gumby
SB20 Nov 22, 2019 2:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What’s going in with SAGE’s options?
Reply
0 0
Report
Fred Adda
Fred Adda Jan 10, 2019 1:04PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The share you HAVE to own in your portfolio
Reply
2 0
Report
Episcopolian OptionTrader
Episcopolian1 Nov 09, 2017 9:27AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$SAGE Next major milestone is Part B Phase 2 data on SAGE-217. Major Depressive Disorder (MDD). Coming next month, although we did get a preview today. Positive!!! $100 handle easy
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email